LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study

Authors

Institutions

Publication Details

Journal
Blood
Published
2024-11-05
DOI
https://doi.org/10.1182/blood-2024-198296
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study

Fuzhe Wang, Sheng Chen, Lingshuang Sheng, Zi‐Xun Yan et al.
Blood
CAR-T cell therapy research
article

LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study

Fuzhe Wang, Sheng Chen, Lingshuang Sheng, Zi‐Xun Yan, Xiaowei Xu, Xuanming Yang, Yilun Zhang, Qi Song, Hongmei Yi, Wang Li, Lei Li, Jianyong Li, Shu Cheng, Pengpeng Xu, Wen Wu, Yuxiang Zhu, Rong Shen, Weiguo Cao, Xufeng Jiang, Wei Zhao, Li Wang
article en

Abstract

No abstract available for this paper.
BloodVol. 144(Supplement 1)
Shanghai Jiao Tong University (CN), Ruijin Hospital (CN), Shanghai Institute of Hematology (CN), Jiangsu Province Hospital (CN), State Key Laboratory of Medical Genomics, Nanjing Medical University (CN)
Good health and well-being
Openalex Percentile: Top 61%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study — Fuzhe Wang, Sheng Chen, et al. · Blood (2024) | TGRS Research Map | TGRS